A new MITEI report outlines actions the U.S. government could take to facilitate large-scale deployment of solar energy, reports Yeganeh Torbati for Reuters. "Ideally ... rather than subsidize investment, we would subsidize production," says Francis O’Sullivan, an author of the report.
Lindsay Kalter reports for The Boston Herald that MIT researchers are developing a device that can be implanted into a tumor to help determine the best course of cancer treatment. “We wanted to bring the laboratory into the human body,” says Langer.
NPR’s Jessica Harris speaks with Prof. Robert Langer about his pioneering work with drug delivery and tissue engineering. “My goals were to do things that I someday thought might improve people’s lives,” says Langer.
Prof. Robert Langer speaks with Chris Baraniuk of New Scientist about winning the Queen Elizabeth Prize for Engineering and his career in biotechnology. “It’s going to be the entrepreneurs, the new professors, the young people who are willing to think outside the box and not necessarily go down a conventional path,” says Langer of the future of medicine.
Michelle Roberts reports for BBC News on a new, “smart insulin” being developed by MIT researchers that switches on when blood sugar rises. The engineered insulin could make it easier for those suffering from diabetes to manage the disease, Roberts explains.
Professor Robert Langer has won the Queen Elizabeth Prize for Engineering for his pioneering work with medical technologies, reports David Shukman for BBC News. Shukman notes that “as many as two billion people have in some way been touched by technologies devised and developed by him and his teams.”
Prof. Robert Langer has been awarded the Queen Elizabeth Prize for Engineering, writes Financial Times reporter Clive Cookson. Lord Broers, chair of the QE Prize judges, explains that Langer was honored for his “immense contribution to healthcare and to numerous other fields.”
Martin LaMonica writes for The Boston Globe about how MIT researchers are creating a commercial prototype of a carbon capture device. Graduate student Aly Eltayeb explains that carbon capture could be useful in cutting carbon emissions, “especially if you can do something with that CO2 and stop treating it as a waste — and treat it as a valuable product.”
Science reporter John Bohannon spotlights Professor Paula Hammond’s chemical engineering lab at MIT and the career paths of her graduate students. Hammond explains that she decided to pursue a career in academia as she “wanted the freedom to pursue my own research,” she explains.
MIT alumnus Noam Angrist and seniors Anisha Gururaj and Elliot H. Akama-Garren were among 32 Rhodes scholars selected from the U.S. this year, reports Jennifer Smith for The Boston Globe. “The American scholars will join an international group of students chosen from 14 other global jurisdictions, according to the Rhodes Trust,” Smith reports.
Two MIT seniors and alumnus Noam Angrist have been named Rhodes Scholars, reports Dave Collins for the Associated Press. “It’s a total dream come true,” says Angrist. “The skills I will get at (Oxford) are just incredible, and I’ll come back into the world fully equipped to do what I love to do.”
Prof. Robert Langer speaks with Trisha Gura of Science about his work as an engineer and entrepreneur. Says Langer of how he became an entrepreneur, “I could see that by having these little companies, you could make an enormous impact.”
Boston Globe reporter Callum Borchers writes about how MIT researchers have developed a new coating that could reduce the risk posed by ingesting batteries. The battery has “been shown in lab tests to deactivate an ingested battery without compromising its performance in electronic devices,” writes Borchers.
In a piece for The Boston Globe, Meredith Goldstein writes that Institute Professor Robert Langer received a Kyoto Prize at a ceremony in Japan for his work with tissue engineering.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”